ClinicalTrials.Veeva

Menu

Comparative Study Between Safety and Effectiveness of High Versus Low Power HOLEP

A

Al-Azhar University

Status

Enrolling

Conditions

Benign Prostatic Hyperplasia

Treatments

Procedure: HOLEP for treating BPH

Study type

Interventional

Funder types

Other

Identifiers

NCT05678452
low and high power HOLEP

Details and patient eligibility

About

Holmium laser enucleation (HOLEP) has became a standard of treatment of large prostates that indicates surgery. HOLEP is widely used nowadays. Many settings are used but no optimal setting was world wide adopted. The aim of this trial is to assess the Low-power Holmium laser enucleation of the prostate (LP-HoLEP)and compare to high-power (HP-HoLEP) for enucleation efficiency pertaining to the advantages of lower cost and minimal postoperative dysuria, storage symptoms, and negative sexual impact.

Enrollment

200 estimated patients

Sex

Male

Ages

45+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • large prostate indicated for surgical intervention.

Exclusion criteria

  • prostate cancer
  • recurrent adenomas
  • associated neurologic factors that may affect outcomes (e.g., neurogenic bladder)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

LP-HoLEP
Active Comparator group
Description:
2J/25Hz setting
Treatment:
Procedure: HOLEP for treating BPH
HP-HoLEP.
Active Comparator group
Description:
2J/50Hz setting
Treatment:
Procedure: HOLEP for treating BPH

Trial contacts and locations

1

Loading...

Central trial contact

Mohamed F Salman, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems